University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

A comparison of the real-life clinical effectiveness of the leading licensed ICS/LABA combination inhalers in the treatment for COPD

Simple item page
dc.contributor.authorMing, Simon Wan Yau
dc.contributor.authorHaughney, John
dc.contributor.authorRyan, Dermot
dc.contributor.authorSmall, Iain
dc.contributor.authorLavorini, Federico
dc.contributor.authorPapi, Alberto
dc.contributor.authorSingh, Dave
dc.contributor.authorHalpin, David M. G.
dc.contributor.authorHurst, John R.
dc.contributor.authorPatel, Shishir
dc.contributor.authorOchel, Matthias
dc.contributor.authorKocks, Janwillem W. H.
dc.contributor.authorCarter, Victoria
dc.contributor.authorHardjojo, Antony
dc.contributor.authorPrice, David
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2020-11-26T10:14:01Z
dc.date.available2020-11-26T10:14:01Z
dc.date.issued2020-11-26
dc.descriptionAcknowledgment The authors extend their thanks to Dr. Kevin Gruffydd-Jones for his clinical and scientific input in the conduct and writing of this study. Dave Singh is supported by the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC). Funding This study was funded by Chiesi Limited. The sponsor is involved in the design and presentation of the study.en
dc.description.statusPeer revieweden
dc.format.extent11
dc.format.extent607146
dc.identifier178528233
dc.identifier9d2b19e2-cbb4-41d8-811a-c69140128229
dc.identifier85097121484
dc.identifier000595400600001
dc.identifier33273812
dc.identifier.citationMing, S W Y, Haughney, J, Ryan, D, Small, I, Lavorini, F, Papi, A, Singh, D, Halpin, D M G, Hurst, J R, Patel, S, Ochel, M, Kocks, J W H, Carter, V, Hardjojo, A & Price, D 2020, 'A comparison of the real-life clinical effectiveness of the leading licensed ICS/LABA combination inhalers in the treatment for COPD', International journal of chronic obstructive pulmonary disease , vol. 15, pp. 3093-3103. https://doi.org/10.2147/COPD.S263745en
dc.identifier.doi10.2147/COPD.S263745
dc.identifier.issn1176-9106
dc.identifier.urihttps://hdl.handle.net/2164/15411
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85097121484&partnerID=8YFLogxKen
dc.identifier.vol15en
dc.language.isoeng
dc.relation.ispartofInternational journal of chronic obstructive pulmonary diseaseen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectMetered Dose Inhaleren
dc.subjectDry Powder Inhaleren
dc.subjectChronic Obstructive Pulmonary Diseaseen
dc.subjectTreatment efficacyen
dc.subjectCost effectivenessen
dc.subjectChronic obstructive pulmonary diseaseen
dc.subjectDry-powder inhaleren
dc.subjectMetered-dose inhaleren
dc.subjectCost-effectivenessen
dc.subjectcost-effectivenessen
dc.subjectPARTICLEen
dc.subjectmetered-dose inhaleren
dc.subjectFORMOTEROLen
dc.subjectBECLOMETHASONE/FORMOTEROLen
dc.subjectDISEASEen
dc.subjectEXACERBATIONSen
dc.subjectASTHMAen
dc.subjectCORTICOSTEROIDSen
dc.subjectAIRWAYSen
dc.subjectdry-powder inhaleren
dc.subjectchronic obstructive pulmonary diseaseen
dc.subjecttreatment efficacyen
dc.subjectR Medicine (General)en
dc.subjectPublic Health, Environmental and Occupational Healthen
dc.subjectHealth Policyen
dc.subjectPulmonary and Respiratory Medicineen
dc.subject.lccR1en
dc.titleA comparison of the real-life clinical effectiveness of the leading licensed ICS/LABA combination inhalers in the treatment for COPDen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Wan_et_al_IJCOD_AcompatisonOfThereal_VoR.pdf
Size:
592.92 KB
Format:
Adobe Portable Document Format
Download

Collections

All research

The Sir Duncan Rice Library

University of Aberdeen

Bedford Road

Aberdeen

AB24 3AA


Tel: +44 (0)1224 273330

Email: library@abdn.ac.uk

Share and keep up to date


FacebookTwitterWordpress